PubMed HealthSearch

Biomedical subjects

Fei Zou

Publications and source records attributed to Fei Zou.

2 recordsLinked to original sources

PETScan: score-based genome-wide association analysis of RNA-Seq and ATAC-Seq data.

MOTIVATION: High-dimensional sequencing data, such as RNA-Seq for gene expression and ATAC-Seq for chromatin accessibility, are widely used in studying systems biology. Accessible chromatin allows transcription factors and regulatory elements to bind to DNA, thereby regulating transcription through the activation or repression of target genes. The association analysis of RNA-Seq and ATAC-Seq data provides insights into gene regulatory mechanisms. Most existing analytic tools exclusively focus on cis-associations, despite regulatory elements being able to physically interact with distant target genes. Furthermore, conventional approaches often utilize Pearson or Spearman correlations, which ignore the count-based nature of RNA-Seq data. RESULTS: To address these limitations, we introduce PETScan, a computationally efficient genome-wide PEak-Transcript Score-based association analysis, utilizing negative binomial models to better accommodate RNA-Seq data. We leverage score tests and matrix calculations for improved computational efficiency, and combine an empirical permutation method with genomic control to ensure valid p-value calculations in studies with limited sample sizes. In real-world datasets, PETScan achieved three orders of magnitude faster than Wald tests, while identifying similar significant gene-peak pairs. AVAILABILITY: The PETScan R package is available on GitHub at https://github.com/yajing-hao/PETScan.

Chromatin Immunoprecipitation Sequencing

Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming.

Pulmonary group 2 innate lymphoid cells (ILC2s) are key drivers of Type 2 inflammation in diseases like asthma, yet the molecular mechanisms regulating their function are incompletely understood. Using the genetically diverse Collaborative Cross (CC) mouse panel, we mapped a quantitative trait locus (QTL) that governs ILC2 prevalence in the lung after aeroallergen exposure. This QTL induces a large population of ILC2s in the lung that are resistant to activation and have diminished Type 2 effector function. We identified free-fatty acid receptor 3 (Ffar3) as a gene responsible for this effect and demonstrated that FFAR3 signaling reprograms ILC2s to an anti-inflammatory state by promoting their survival, reducing Type 2 cytokine production, and enhancing IL-10 expression. This anti-inflammatory state is dependent on IL-2 signaling, is characterized by decreased ST2 expression, and is distinct from previously described IL-10-producing ILC2 phenotypes. FFAR3-dependent reprogramming is mediated by epidermal growth factor receptor (EGFR) upregulation, and FFAR3's anti-inflammatory effect is partially conserved in human ILC2s.

Animals